Korro Bio Cash Flow Statement (2018-2026) | KRRO

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M62.30M-23.39M-25.77M-18.06M92.90M-19.62M
Depreciation and Depletion (Quarter)
0.92M0.73M0.74M0.73M0.69M0.68M0.42M0.81M0.49M0.39M0.98M0.70M0.70M0.90M1.30M1.23M1.20M1.20M0.65M0.40M
Share-based Compensation (Quarter)
6.09M5.89M5.16M5.27M4.56M5.59M-14.29M0.35M0.40M0.40M1.23M0.86M0.97M1.27M1.36M1.76M2.00M1.82M2.07M2.73M
Asset Writedowns and Impairment (Quarter)
15.00M
Cash from Operations (Quarter)
-17.67M-15.02M-17.89M-17.34M-13.48M-11.80M-11.03M-19.69M-14.71M-11.77M-21.11M-21.89M-14.59M-16.09M-7.50M-24.45M-19.23M-17.18M-17.70M-16.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.07M0.01M0.00M0.17M0.99M0.62M0.34M0.08M0.05M0.02M-0.00M
Depreciation & Amortization (CF) (Quarter)
0.92M0.73M0.74M0.73M0.69M0.68M0.42M0.81M0.49M0.39M0.98M0.70M0.70M0.90M1.30M1.23M1.20M1.20M0.65M0.40M
Change in Working Capital
Change in Receivables (Quarter)
1.70M0.23M-0.83M-0.27M0.15M-0.97M
Change in Account Payables (Quarter)
-0.51M0.45M-0.38M-0.43M1.23M-0.34M1.30M0.55M-0.20M-0.04M2.79M-2.58M2.08M-0.23M-0.60M0.10M1.09M-2.87M-0.64M-0.15M
Change in Accured Expenses (Quarter)
1.26M1.57M0.80M-1.35M0.73M0.23M0.36M-1.12M0.90M1.95M-0.46M-5.05M1.00M-0.72M0.80M-2.51M2.00M0.19M1.75M-0.20M
Other Working Capital Changes (Quarter)
-0.91M-1.64M3.06M-1.39M-0.25M-1.56M3.22M0.34M-0.35M0.03M-0.01M0.29M-0.46M-0.06M9.65M0.41M0.04M-0.26M-1.78M-0.13M
Investing Activities
Capital Expenditures (Quarter)
-1.03M2.09M0.06M0.01M0.00M-0.02M5.14M1.51M4.42M0.25M1.66M5.61M5.96M4.88M1.45M0.12M0.14M0.17M0.08M0.02M
Change in Acquisitions & Divestments (Quarter)
2.50M15.10M11.63M8.14M23.35M21.99M0.02M17.00M1.00M1.00M14.00M26.90M32.90M0.00M22.80M15.00M13.00M
Cash from Investing Activities (Quarter)
-16.86M-8.41M-14.65M-12.66M6.02M13.21M4.49M15.49M-3.42M0.75M-1.66M-5.61M-102.39M-12.58M-2.77M32.78M-11.30M7.60M14.92M-32.24M
Financing Activities
Other financing activities (Quarter)
0.06M-0.00M0.14M0.06M-0.13M-0.15M0.28M0.22M-0.35M0.14M67.25M100.00M0.18M-0.18M0.69M0.02M
Cash from Financing Activities (Quarter)
0.33M0.35M0.11M0.20M0.06M-0.24M45.40M-0.04M-2.19M144.59M0.14M67.56M0.73M0.93M0.17M0.01M0.13M0.38M88.21M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.33M0.29M0.11M0.06M-0.00M-0.06M0.00M-0.00M117.25M100.00M83.15M
Additional items
Exchange Rate Effect (Quarter)
-0.00M-0.01M-0.00M0.07M-0.03M
Change in Cash (Quarter)
-34.20M-23.09M-32.43M-29.80M-7.46M1.47M-6.78M41.20M-18.17M-13.21M121.83M-27.36M-49.43M-27.95M-9.33M8.50M-30.53M-9.46M-2.33M39.87M
Free Cash Flow (Quarter)
-16.64M-17.12M-17.95M-17.36M-13.48M-11.78M-16.16M-21.20M-19.14M-12.02M-22.76M-27.50M-20.55M-20.97M-8.95M-24.57M-19.37M-17.35M-17.79M-16.09M
Net Cash Flow (Quarter)
-34.20M-23.09M-32.43M-29.80M-7.46M1.47M-6.78M41.20M-18.17M-13.21M121.83M-27.36M-49.43M-27.95M-9.33M8.50M-30.52M-9.46M-2.41M39.90M